Re: Caplyta

Posted by undopaminergic on January 17, 2020, at 14:10:30

In reply to Caplyta » alexandra_k, posted by phidippus on January 17, 2020, at 12:07:55

> Caplyta. I found it.
>
> Lumateperone (INN; brand name Caplyta kəp-LY-tə, developmental codes ITI-007 and ITI-722) is a butyrophenone atypical antipsychotic developed by Intra-Cellular Therapies, licensed from Bristol-Myers Squibb, for the treatment of schizophrenia,[1] and currently in development for bipolar depression and other neurological indications.
>
Is bipolar depression a neurological indication now?
-undopaminergic

Thread

New antipsychotic that starts with a C? phidippus 1/15/20
Re: New antipsychotic that starts with a C? beckett2 1/16/20
Re: New antipsychotic that starts with a C? alexandra_k 1/16/20
Caplyta » alexandra_k phidippus 1/17/20
Re: Caplyta undopaminergic 1/17/20
Re: Caplyta » undopaminergic phidippus 1/17/20

Post a new follow-up

Notify the administrators

Start a new thread

poster:undopaminergic thread:1107961
URL: http://www.dr-bob.org/babble/20200104/msgs/1107999.html